Hill G S, Delahousse M, Nochy D, Rémy P, Mignon F, Méry J P, Bariéty J
Hôpitaux Broussais, St. Louis, Henri Mondor, and Bichat, Paris, France.
Kidney Int. 2001 Jan;59(1):304-16. doi: 10.1046/j.1523-1755.2001.00492.x.
A new Biopsy Index containing the Glomerular Activity (GAI), Tubulointerstitial Activity (TIAI), Chronic Lesion (CLI), and Immunofluorescence (IFI) indices was developed, showing better correlations with clinical and outcome parameters than the National Institutes of Health Activity and Chronicity Indices (AI and CI) in lupus nephritis. This report examines the ability of these indices and individual morphologic variables to predict doubling of serum creatinine (SCr; CRX2).
Renal biopsies from 71 patients with lupus nephritis with an initial biopsy (Bx1) and systematic control biopsy (Bx2) after six months of therapy were studied. Kaplan-Meier survival curves were developed for each index and morphologic variable at each biopsy. A subset of 30 biopsies was stained with the macrophage marker PGM1.
At Bx1, only the TIAI and the quantity of C3 and vascular staining on IF were predictive of CRX2. At Bx2, particularly predictive of CRX2 were the GAI, IFI, Biopsy Index, and BxInfl, a composite variable comprised of all of the inflammatory variables. Among individual variables, glomerular and tubular macrophages correlated the best with clinical and outcome parameters. Crescents and karyorrhexis/fibrinoid necrosis also correlated with outcome. Neither the NIH CI or our CLI, nor the TIAI correlated with outcome. In 30 biopsies stained with PGM1, PGM1+ cells correlated well with glomerular and tubular macrophages identified on routine stains and showed even better correlations with SCr, proteinuria, and progression to renal insufficiency than the latter. A diffuse membranoproliferative (MPGN) pattern was seen in seven patients at Bx1. In four of the seven patients, MPGN disappeared with therapy, and all finished with normal renal function. However, among the three patients in whom MPGN persisted and eight patients in whom MPGN, focal or diffuse, appeared under therapy, six reached end-stage renal disease, and a seventh died with marked renal insufficiency.
The biopsy index and its components correlate modestly with CRX2 at Bx1, but strongly at Bx2, particularly IFI, BxInfl, and glomerular and tubular macrophages. Stains for macrophage markers form a valuable adjunct in interpretation of renal biopsies in systemic lupus erythematosus (SLE). MPGN features do not have an ominous significance at Bx1, but their persistence or appearance under therapy are associated with poor outcome.
一种新的活检指数被开发出来,它包含肾小球活动指数(GAI)、肾小管间质活动指数(TIAI)、慢性病变指数(CLI)和免疫荧光指数(IFI),在狼疮性肾炎中,该指数与临床及预后参数的相关性优于美国国立卫生研究院活动指数和慢性指数(AI和CI)。本报告研究了这些指数及个体形态学变量预测血清肌酐翻倍(SCr;CRX2)的能力。
对71例狼疮性肾炎患者的肾活检组织进行研究,这些患者在初始活检(Bx1)后接受了6个月的治疗,并进行了系统性对照活检(Bx2)。为每次活检时的每个指数和形态学变量绘制Kaplan-Meier生存曲线。对30例活检组织用巨噬细胞标志物PGM1进行染色。
在Bx1时,只有TIAI以及免疫荧光上C3的量和血管染色可预测CRX2。在Bx2时,特别能预测CRX2的是GAI、IFI、活检指数以及BxInfl,BxInfl是一个由所有炎症变量组成的复合变量。在个体变量中,肾小球和肾小管巨噬细胞与临床及预后参数的相关性最佳。新月体和核碎裂/纤维蛋白样坏死也与预后相关。美国国立卫生研究院慢性指数(NIH CI)或我们的CLI以及TIAI均与预后无关。在30例用PGM1染色的活检组织中,PGM1+细胞与常规染色鉴定出的肾小球和肾小管巨噬细胞相关性良好,并且与SCr、蛋白尿以及进展至肾功能不全的相关性甚至比后者更好。在Bx1时,7例患者出现弥漫性膜增生性肾小球肾炎(MPGN)。在这7例患者中的4例,MPGN在治疗后消失,所有患者最终肾功能正常。然而,在MPGN持续存在的3例患者以及治疗过程中出现局灶性或弥漫性MPGN的8例患者中,6例发展至终末期肾病,第7例死于严重肾功能不全。
活检指数及其组成部分在Bx1时与CRX2的相关性一般,但在Bx2时相关性较强,特别是IFI、BxInfl以及肾小球和肾小管巨噬细胞。巨噬细胞标志物染色在系统性红斑狼疮(SLE)肾活检的解读中是一种有价值的辅助手段。MPGN特征在Bx1时并无不祥之兆,但其在治疗过程中的持续存在或出现与不良预后相关。